{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:19:18Z","timestamp":1793755158169,"version":"4.6.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jacc.2025.09.1603","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:23:12Z","timestamp":1764170592000},"page":"723-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sex Differences in Dilated Cardiomyopathy"],"prefix":"10.1016","volume":"87","author":[{"given":"Sophie L.V.M.","family":"Stroeks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanelle","family":"Oko-Osi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Arasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasana (Paz)","family":"Tayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.09.1603_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","article-title":"Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches","volume":"402","author":"Heymans","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.09.1603_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.124.070872","article-title":"Systematic review, meta-analysis, and population study to determine the biologic sex ratio in dilated cardiomyopathy","volume":"151","author":"Bergan","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.14740\/cr2071","article-title":"Prevalence and incidence of dilated cardiomyopathy in the United States and Western Europe: a systematic review","volume":"16","author":"Myers","year":"2025","journal-title":"Cardiol Res"},{"key":"10.1016\/j.jacc.2025.09.1603_bib5","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ejhf.1216","article-title":"Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy","volume":"20","author":"Halliday","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112289","article-title":"Sex differences, genetic and environmental influences on dilated cardiomyopathy","volume":"10","author":"Jain","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.122.003704","article-title":"Prevalence and disease expression of pathogenic and likely pathogenic variants associated with inherited cardiomyopathies in the general population","volume":"15","author":"Bourfiss","year":"2022","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006832","article-title":"Clinical phenotypes and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene","volume":"13","author":"Akhtar","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib10","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.jacc.2017.08.063","article-title":"Phenotype and clinical outcomes of titin cardiomyopathy","volume":"70","author":"Tayal","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","article-title":"Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals","volume":"106","author":"Kayvanpour","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib12","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/europace\/euab183","article-title":"Clinical characteristics and risk stratification of desmoplakin cardiomyopathy","volume":"24","author":"Wang","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2025.09.1603_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/CIRCGEN.123.004221","article-title":"DMD-associated dilated cardiomyopathy: genotypes, phenotypes, and phenocopies","volume":"16","author":"Johnson","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrcardio.2009.105","article-title":"Gender differences in the cardiovascular effect of sex hormones","volume":"6","author":"Vitale","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102564","article-title":"Effects of sex and 17\u03b2-estradiol on cardiac fibroblast morphology and signaling activities in vitro","volume":"10","author":"Watts","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jacc.2025.09.1603_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00018-023-04886-6","article-title":"Estradiol mitigates stress-induced cardiac injury and inflammation by downregulating ADAM17 via the GPER-1\/PI3K signaling pathway","volume":"80","author":"Adu-Amankwaah","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jacc.2025.09.1603_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/aja.aja_80_20","article-title":"Testosterone, cardiomyopathies, and heart failure: a narrative review","volume":"23","author":"Diaconu","year":"2021","journal-title":"Asian J Androl"},{"key":"10.1016\/j.jacc.2025.09.1603_bib19","doi-asserted-by":"crossref","first-page":"H2043","DOI":"10.1152\/ajpheart.01121.2005","article-title":"Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function","volume":"290","author":"Cavasin","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100320","article-title":"Endogenous sex hormone levels and myocardial fibrosis in men and postmenopausal women","volume":"2","author":"Chehab","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacc.2025.09.1603_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5523516","article-title":"Protective effects of estrogen on cardiovascular disease mediated by oxidative stress","volume":"2021","author":"Xiang","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jacc.2025.09.1603_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga","year":"2017","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.jacc.2025.09.1603_bib23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.283.9.1183","article-title":"Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review","volume":"283","author":"Pearson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.1603_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjcard.2007.02.092","article-title":"Incidence, mortality, and racial differences in peripartum cardiomyopathy","volume":"100","author":"Brar","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(06)69253-2","article-title":"Peripartum cardiomyopathy","volume":"368","author":"Sliwa","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.09.1603_bib26","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCULATIONAHA.120.052395","article-title":"Genetic and phenotypic landscape of peripartum cardiomyopathy","volume":"143","author":"Goli","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib28","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ejhf.1624","article-title":"Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities","volume":"21","author":"Moulig","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamacardio.2025.0328","article-title":"Hypertensive disorders of pregnancy and long-term risk of dilated cardiomyopathy","volume":"10","author":"Tayal","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/GME.0000000000000138","article-title":"Age at menopause and incident heart failure: the Multi-Ethnic Study of Atherosclerosis","volume":"21","author":"Ebong","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.jacc.2025.09.1603_bib31","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/jog.12368","article-title":"Menopausal cardiomyopathy: does it really exist? A case-control deformation imaging study","volume":"40","author":"Keskin Kurt","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.jacc.2025.09.1603_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2025.09.1603_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jchf.2024.08.011","article-title":"Genetic landscape of patients with dilated cardiomyopathy and a systemic immune-mediated disease","volume":"13","author":"Stroeks","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115373","article-title":"Anti-breast cancer-induced cardiomyopathy: mechanisms and future directions","volume":"166","author":"Liu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jacc.2025.09.1603_bib35","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cardfail.2023.10.477","article-title":"Sex differences in the development of anthracycline-associated heart failure","volume":"30","author":"Diaz","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.peptides.2015.03.023","article-title":"Prediction of all-cause mortality with copeptin in cardio-cerebrovascular patients: a meta-analysis of prospective studies","volume":"69","author":"Sun","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.jacc.2025.09.1603_bib37","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib38","doi-asserted-by":"crossref","first-page":"H1453","DOI":"10.1152\/ajpheart.00554.2015","article-title":"Drug-induced mitochondrial dysfunction and cardiotoxicity","volume":"309","author":"Varga","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib39","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/eurheartj\/ehae362","article-title":"Alcoholic cardiomyopathy: an update","volume":"45","author":"Dom\u00ednguez","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.09.1603_bib40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/clc.23067","article-title":"National trends in hospitalizations and outcomes in patients with alcoholic cardiomyopathy","volume":"41","author":"Ram","year":"2018","journal-title":"Cli Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib41","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2018.03.462","article-title":"Genetic etiology for alcohol-induced cardiac toxicity","volume":"71","author":"Ware","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jchf.2023.10.009","article-title":"Sex differences in the clinical presentation and natural history of dilated cardiomyopathy","volume":"12","author":"Owen","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169007","article-title":"Titin truncating variants in dilated cardiomyopathy\u2014prevalence and genotype-phenotype correlations","volume":"12","author":"Franaszczyk","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.09.1603_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000474","article-title":"Clinical disease presentation and ECG characteristics of LMNA mutation carriers","volume":"4","author":"Ollila","year":"2017","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2025.09.1603_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005700","article-title":"Pathogenic RBM20-variants are associated with a severe disease expression in male patients with dilated cardiomyopathy","volume":"12","author":"Hey","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2021.100299","article-title":"Addressing the bias in cardiovascular care: missed & delayed diagnosis of cardiovascular disease in women","volume":"8","author":"Johnson","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jacc.2017.05.024","article-title":"Knowledge, attitudes, and beliefs regarding cardiovascular disease in women: the Women\u2019s Heart Alliance","volume":"70","author":"Bairey Merz","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib48","first-page":"37","article-title":"Sex differences in the long-term prognosis of dilated cardiomyopathy","volume":"36","author":"Cannat\u00e0","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jamacardio.2021.5890","article-title":"Association of titin variations with late-onset dilated cardiomyopathy","volume":"7","author":"Cannat\u00e0","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2018.09.081","article-title":"Differential impact of heart failure with reduced ejection fraction on men and women","volume":"73","author":"Dewan","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ejhf.2154","article-title":"Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire","volume":"23","author":"Ravera","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cardfail.2008.09.006","article-title":"Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls","volume":"15","author":"Lesman-Leegte","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2011.03.042","article-title":"Influence of sex and hormone status on circulating natriuretic peptides","volume":"58","author":"Lam","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib54","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/CIRCULATIONAHA.123.064386","article-title":"Sex differences in cardiac troponin trajectories over the life course","volume":"147","author":"de Bakker","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.17153","article-title":"Sex differences in the risk of first and recurrent ventricular tachyarrhythmias among patients receiving an implantable cardioverter-defibrillator for primary prevention","volume":"5","author":"Saxena","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.09.1603_bib56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/eurjhf\/hfq009","article-title":"Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction >35%: a PROSPECT trial substudy","volume":"12","author":"Chung","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib57","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/CIRCULATIONAHA.105.574400","article-title":"Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume","volume":"113","author":"Chung","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib58","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.119.044491","article-title":"Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF","volume":"141","author":"McMurray","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib59","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","article-title":"Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT trial","volume":"7","author":"Merrill","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jacc.2009.08.036","article-title":"Pregnancy outcomes in women with dilated cardiomyopathy","volume":"55","author":"Grewal","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jjcc.2020.07.007","article-title":"Pregnancy outcomes in women with dilated cardiomyopathy: peripartum cardiovascular events predict post delivery prognosis","volume":"77","author":"Yokouchi-Konishi","year":"2021","journal-title":"J Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.recesp.2024.04.002","article-title":"Pregnancy in women with dilated cardiomyopathy genetic variants","volume":"78","author":"Restrepo-C\u00f3rdoba","year":"2025","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jacc.2025.09.1603_bib63","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1161\/01.CIR.0000015699.48605.08","article-title":"Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease","volume":"105","author":"Siu","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib64","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100832","article-title":"Long-term arrhythmic follow-up and risk stratification of patients with desmoplakin-associated arrhythmogenic right ventricular cardiomyopathy","volume":"3","author":"Gasperetti","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacc.2025.09.1603_bib67","first-page":"2968","article-title":"A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers","volume":"45","author":"Carrick","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.09.1603_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","article-title":"Evidence-based assessment of genes in dilated cardiomyopathy","volume":"144","author":"Jordan","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib69","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005220","article-title":"Clinical phenotype and genotype associations with improvement in left ventricular function in dilated cardiomyopathy","volume":"11","author":"Verdonschot","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib70","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/fcp.12313","article-title":"The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case\/noncase study in VigiBase","volume":"31","author":"Alharbi","year":"2017","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib71","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1161\/CIRCULATIONAHA.106.673442","article-title":"Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"115","author":"O\u2019Meara","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib72","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/clc.22658","article-title":"Predictors and long-term outcome of super-responders to cardiac resynchronization therapy","volume":"40","author":"Ghani","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib73","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa021266","article-title":"Sex-based differences in the effect of digoxin for the treatment of heart failure","volume":"347","author":"Rathore","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib74","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib75","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib76","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038249","article-title":"Comprehensive analysis of the effects of sacubitril\/valsartan according to sex among patients with heart failure and reduced ejection fraction in PARADIGM-HF","volume":"14","author":"Chimura","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.09.1603_bib77","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib78","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(19)31792-1","article-title":"Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study","volume":"394","author":"Santema","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.09.1603_bib79","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11044","article-title":"Association of gender and race with allocation of advanced heart failure therapies","volume":"3","author":"Breathett","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jacc.2025.09.1603_bib80","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/CIRCULATIONAHA.123.067489","article-title":"Sex disparities in longitudinal use and intensification of guideline-directed medical therapy among patients with newly diagnosed heart failure with reduced ejection fraction","volume":"149","author":"Sumarsono","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.1603_bib81","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cardfail.2024.10.288","article-title":"Underutilization and sex disparities in real world heart failure guideline directed therapy prescription rates over time in a large health system","volume":"31","author":"Rasmusson","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib82","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10741-022-10275-1","article-title":"Sex-specific differences in the efficacy of heart failure therapies: a meta-analysis of 84,818 patients","volume":"28","author":"Wang","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2025.09.1603_bib83","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jce.12701","article-title":"Sex differences in device therapies for ventricular arrhythmias or death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial","volume":"26","author":"Tompkins","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib84","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamainternmed.2014.2717","article-title":"Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data","volume":"174","author":"Zusterzeel","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.09.1603_bib85","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1540-8167.2008.01129.x","article-title":"Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial","volume":"19","author":"Russo","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib86","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jacc.2020.05.061","article-title":"Long-term outcomes of implantable cardioverter-defibrillator therapy in the SCD-HeFT","volume":"76","author":"Poole Jeanne","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.1603_bib87","article-title":"Underrepresentation of women in implantable cardioverter defibrillator trials","volume":"14","author":"Han","year":"2022","journal-title":"Am Heart J Plus"},{"key":"10.1016\/j.jacc.2025.09.1603_bib88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.hrthm.2022.08.018","article-title":"Differences in mode of death between men and women receiving implantable cardioverter-defibrillators or cardiac resynchronization therapy in the MADIT trials","volume":"20","author":"Tompkins","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.09.1603_bib89","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jchf.2023.08.020","article-title":"Clinical outcomes with a fully magnetically levitated left ventricular assist device among women and men","volume":"11","author":"Ramu","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.09.1603_bib90","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1111\/jocs.16933","article-title":"Toward equitable utilization of durable left ventricular assist device therapy in advanced heart failure\u2014raising the veil of health disparities","volume":"37","author":"Mazimba","year":"2022","journal-title":"J Card Surg"},{"key":"10.1016\/j.jacc.2025.09.1603_bib91","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1210\/jc.2009-1789","article-title":"Early age at menarche associated with cardiovascular disease and mortality","volume":"94","author":"Lakshman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2025.09.1603_bib92","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.gme.0000218683.97338.ea","article-title":"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis","volume":"13","author":"Atsma","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.jacc.2025.09.1603_bib93","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jacc.2025.04.068","article-title":"Sex differences in the genetic causes of dilated cardiomyopathy","volume":"86","author":"Mangino","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2025.09.1603_bib94","article-title":"Arrhythmic risk stratification of filamin C truncating variants carriers","volume":"44","author":"Gigli","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.09.1603_bib95","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers\u2014reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur Heart J"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725098110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725098110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:05:48Z","timestamp":1771344348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725098110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0735109725098110"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.09.1603","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex Differences in Dilated Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.09.1603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}